Literature DB >> 27328806

Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.

Lalantha Leelarathna1,2, Hood Thabit2,3, Sara Hartnell3, Malgorzata E Willinska2,4, Sibylle Dellweg5, Carsten Benesch5, Julia K Mader6, Manuel Holzer6, Harald Kojzar6, Mark L Evans2,3, Sabine Arnolds5, Thomas R Pieber6, Roman Hovorka2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27328806      PMCID： PMC5375064          DOI： 10.1177/1932296816654715

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  4 in total

1.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

2.  Home Use of an Artificial Beta Cell in Type 1 Diabetes.

Authors:  H Thabit; M Tauschmann; J M Allen; L Leelarathna; S Hartnell; M E Wilinska; C L Acerini; S Dellweg; C Benesch; L Heinemann; J K Mader; M Holzer; H Kojzar; J Exall; J Yong; J Pichierri; K D Barnard; C Kollman; P Cheng; P C Hindmarsh; F M Campbell; S Arnolds; T R Pieber; M L Evans; D B Dunger; R Hovorka
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

3.  Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.

Authors:  Lalantha Leelarathna; Sibylle Dellweg; Julia K Mader; Katharine Barnard; Carsten Benesch; Martin Ellmerer; Lutz Heinemann; Harald Kojzar; Hood Thabit; Malgorzata E Wilinska; Tim Wysocki; Thomas R Pieber; Sabine Arnolds; Mark L Evans; Roman Hovorka
Journal:  BMJ Open       Date:  2014-09-03       Impact factor: 2.692

4.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Authors:  T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder
Journal:  Diabetologia       Date:  2012-09-11       Impact factor: 10.122
  4 in total
  3 in total

1.  Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.

Authors:  Eyal Dassau; Jordan E Pinsker; Yogish C Kudva; Sue A Brown; Ravi Gondhalekar; Chiara Dalla Man; Steve Patek; Michele Schiavon; Vikash Dadlani; Isuru Dasanayake; Mei Mei Church; Rickey E Carter; Wendy C Bevier; Lauren M Huyett; Jonathan Hughes; Stacey Anderson; Dayu Lv; Elaine Schertz; Emma Emory; Shelly K McCrady-Spitzer; Tyler Jean; Paige K Bradley; Ling Hinshaw; Alejandro J Laguna Sanz; Ananda Basu; Boris Kovatchev; Claudio Cobelli; Francis J Doyle
Journal:  Diabetes Care       Date:  2017-10-13       Impact factor: 19.112

2.  Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability.

Authors:  Anna M Lindmeyer; Juris J Meier; Michael A Nauck
Journal:  J Diabetes Sci Technol       Date:  2020-08-18

3.  Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden.

Authors:  Johan Jendle; Jayne Smith-Palmer; Alexis Delbaere; Simona de Portu; Natalie Papo; William Valentine; Stéphane Roze
Journal:  Diabetes Ther       Date:  2017-09-04       Impact factor: 2.945
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.